A Drug-Drug Interaction Study to Evaluate the Effect of Smoking (CYP1A2 Inducer) on the Pharmacokinetics Following a Single Oral Dose of GS1-144 Tablets in Chinese Healthy Postmenopausal Female Trial Participants
Latest Information Update: 23 Apr 2026
At a glance
- Drugs GS1 144 (Primary)
- Indications Postmenopause
- Focus Pharmacokinetics
- Sponsors GeneScience Pharmaceuticals
Most Recent Events
- 23 Apr 2026 New trial record